List of Tables
Table 1. Global Infant and Child Multiple Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Infant and Child Multiple Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Infant and Child Multiple Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Infant and Child Multiple Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Infant and Child Multiple Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Infant and Child Multiple Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Infant and Child Multiple Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Infant and Child Multiple Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Infant and Child Multiple Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Infant and Child Multiple Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Infant and Child Multiple Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Infant and Child Multiple Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infant and Child Multiple Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infant and Child Multiple Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infant and Child Multiple Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Infant and Child Multiple Vaccine Sales by Region (2020-2025) & (M Doses)
Table 18. Global Infant and Child Multiple Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Infant and Child Multiple Vaccine Sales by Region (2026-2031) & (M Doses)
Table 20. Global Infant and Child Multiple Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Infant and Child Multiple Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Infant and Child Multiple Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Infant and Child Multiple Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Infant and Child Multiple Vaccine Sales by Country (2020-2025) & (M Doses)
Table 27. North America Infant and Child Multiple Vaccine Sales by Country (2026-2031) & (M Doses)
Table 28. North America Infant and Child Multiple Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Infant and Child Multiple Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Infant and Child Multiple Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Infant and Child Multiple Vaccine Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Infant and Child Multiple Vaccine Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Infant and Child Multiple Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Infant and Child Multiple Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Infant and Child Multiple Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Infant and Child Multiple Vaccine Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Infant and Child Multiple Vaccine Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Infant and Child Multiple Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Infant and Child Multiple Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Infant and Child Multiple Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Infant and Child Multiple Vaccine Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Infant and Child Multiple Vaccine Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Infant and Child Multiple Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Infant and Child Multiple Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Infant and Child Multiple Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Infant and Child Multiple Vaccine Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Infant and Child Multiple Vaccine Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Infant and Child Multiple Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Infant and Child Multiple Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Infant and Child Multiple Vaccine Sales (M Doses) by Type (2020-2025)
Table 51. Global Infant and Child Multiple Vaccine Sales (M Doses) by Type (2026-2031)
Table 52. Global Infant and Child Multiple Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Infant and Child Multiple Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Infant and Child Multiple Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Infant and Child Multiple Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Infant and Child Multiple Vaccine Sales (M Doses) by Application (2020-2025)
Table 61. Global Infant and Child Multiple Vaccine Sales (M Doses) by Application (2026-2031)
Table 62. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Infant and Child Multiple Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Infant and Child Multiple Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Sanofi Infant and Child Multiple Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. GSK Infant and Child Multiple Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Company Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Company Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. KM Biologics Infant and Child Multiple Vaccine Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Company Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Company Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Walvax Biotechnology Infant and Child Multiple Vaccine Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Company Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Company Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Minhai Biotechnology Infant and Child Multiple Vaccine Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Infant and Child Multiple Vaccine Distributors List
Table 113. Infant and Child Multiple Vaccine Customers List
Table 114. Infant and Child Multiple Vaccine Market Trends
Table 115. Infant and Child Multiple Vaccine Market Drivers
Table 116. Infant and Child Multiple Vaccine Market Challenges
Table 117. Infant and Child Multiple Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Infant and Child Multiple Vaccine
Figure 2. Global Infant and Child Multiple Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Infant and Child Multiple Vaccine Market Share by Type: 2024 & 2031
Figure 4. Pentavalent Vaccine Product Picture
Figure 5. Quadruple Vaccine Product Picture
Figure 6. Triple Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Infant and Child Multiple Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Infant and Child Multiple Vaccine Market Share by Application: 2024 & 2031
Figure 10. 12 Months Below
Figure 11. 12 Months Above
Figure 12. Global Infant and Child Multiple Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Infant and Child Multiple Vaccine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Infant and Child Multiple Vaccine Sales (2020-2031) & (M Doses)
Figure 15. Global Infant and Child Multiple Vaccine Average Price (US$/Dose) & (2020-2031)
Figure 16. Infant and Child Multiple Vaccine Report Years Considered
Figure 17. Infant and Child Multiple Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Infant and Child Multiple Vaccine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Infant and Child Multiple Vaccine Players: Market Share by Revenue in Infant and Child Multiple Vaccine in 2024
Figure 20. Infant and Child Multiple Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Infant and Child Multiple Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Infant and Child Multiple Vaccine Sales Market Share by Country (2020-2031)
Figure 23. North America Infant and Child Multiple Vaccine Revenue Market Share by Country (2020-2031)
Figure 24. United States Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Infant and Child Multiple Vaccine Sales Market Share by Country (2020-2031)
Figure 27. Europe Infant and Child Multiple Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Infant and Child Multiple Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Infant and Child Multiple Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. China Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Infant and Child Multiple Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Infant and Child Multiple Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Infant and Child Multiple Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Infant and Child Multiple Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Infant and Child Multiple Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Infant and Child Multiple Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Infant and Child Multiple Vaccine by Type (2020-2031)
Figure 54. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Type (2020-2031)
Figure 55. Global Sales Market Share of Infant and Child Multiple Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Infant and Child Multiple Vaccine by Application (2020-2031)
Figure 57. Global Infant and Child Multiple Vaccine Price (US$/Dose) by Application (2020-2031)
Figure 58. Infant and Child Multiple Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
